Conditions

Researchers identified increases in three miRNAs and decreases in seven miRNAs in patients with type 2 diabetes…. 

Our publisher, Steve Freed, had a chance to talk with Dr. Stanley Schwartz, asking questions and getting some in-depth and very informative answers on exactly how SGLT-2 Inhibitors work.  Steve Freed: Regarding the SGLT2 drugs that are now available, I know that a lot of physicians just refuse to write …

In this Homerun Slides series, we review some issues around the Diabetic Management of the Obese Patient including; Potential Causes of Weight Gain with Treatment of Type 2 Diabetes; Weight Reduction Issues – Non-Insulin; and treatment with SGLT-2 Inhibitors with Incretins (GLP-1’s or DPP-IV’s)…. See more SGLT-2 Resources To download …

Richard S. Beaser, MD This week’s excerpt addresses the following topics: What is the "Incretin Effect"? The seven actions of GLP-1 Efficacy of DPP-IV inhibitors Where do the bile acid sequestrants fit in?

Incremental association among those with higher body mass indexes…. 

  This week’s Homerun Slides set covers weight reduction through lifestyle modification as well as some of the newer medications available to help your patients achieve this important goal….

Richard S. Beaser, MD This week’s excerpt covers the following topics: Which medications slow glucose absorption? Which medications increase insulin secretion? What is first phase insulin response? Who are the patient candidates for the different drug classes? Nateglinide vs. Repaglinide  

Short course of intensive insulin therapy can impact beta-cell function and glucose variability…. 

Effect of frequent, self-monitoring of blood glucose may not be significant…. 

Some dairy subgroups may be beneficial for diabetes prevention….